Wiggins v. United States
24-6410
| SCOTUS | Jun 30, 2025Background
- Antoine Wiggins petitioned the Supreme Court following a Third Circuit decision involving the definition of a "controlled substance offense" under federal sentencing guidelines (USSG §4B1.2(b)).
- There is a split among federal appellate courts regarding whether a "controlled substance offense" must relate to drugs prohibited under state law, federal law, or either.
- The U.S. Sentencing Commission had previously been unable to address this issue due to lacking a quorum but regained the ability to amend guidelines in 2022.
- Despite acknowledging the circuit split, the Sentencing Commission has not yet resolved the issue and has not included it in its priorities for the 2025–2026 amendment cycle.
- This ambiguity affects whether certain defendants are classified as "career offenders" under the Guidelines, potentially leading to significant sentencing disparities based solely on geographic location.
- The Supreme Court denied certiorari, but Justices Sotomayor and Barrett issued a statement highlighting the need for uniformity and urging Commission action or, absent that, potential Supreme Court intervention.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Definition of "controlled substance offense" | Should use state law or both; differential treatment unfair | Should use federal law; promotes uniformity | Cert denied; issue not resolved; split persists |
| Sentencing disparities | Location-based sentencing disparities are arbitrary and unfair | Existing guidelines are sufficient | Cert denied; disparities remain |
| Role of Sentencing Commission | Commission should resolve the split | Commission compliance not addressed | Commission urged to act |
| Supreme Court intervention if Commission inaction | Court should step in if Commission fails | Oppose Supreme Court involvement preemptively | No action; issue left open |
Key Cases Cited
- Braxton v. United States, 500 U.S. 344 (1991) (Recognized Sentencing Commission's responsibility to ensure consistent guideline application)
